Knowledge (XXG)

Weakness

Source 📝

390:
conditions of the local muscle affected, whereas the central model of muscle fatigue is an integrated mechanism that works to preserve the integrity of the system by initiating muscle fatigue through muscle derecruitment, based on collective feedback from the periphery, before cellular or organ failure occurs. Therefore, the feedback that is read by this central regulator could include chemical and mechanical as well as cognitive cues. The significance of each of these factors will depend on the nature of the fatigue-inducing work that is being performed.
419: 127:. Fatigue (reduced ability to generate force) may occur due to the nerve, or within the muscle cells themselves. New research from scientists at Columbia University suggests that muscle fatigue is caused by calcium leaking out of the muscle cell. This makes less calcium available for the muscle cell. In addition, the Columbia researchers propose that an enzyme activated by this released calcium eats away at muscle fibers. 372:
Peripheral muscle fatigue during physical work is considered an inability for the body to supply sufficient energy or other metabolites to the contracting muscles to meet the increased energy demand. This is the most common case of physical fatigue—affecting a national average of 72% of adults in the
359:
following the workout. Part of the process of strength training is increasing the nerve's ability to generate sustained, high frequency signals which allow a muscle to contract with their greatest force. It is this "neural training" that causes several weeks worth of rapid gains in strength, which
290:
meaning "muscle" + -asthenia meaning "weakness"), or simply muscle weakness, is a lack of muscle strength. The causes are many and can be divided into conditions that have either true or perceived muscle weakness. True muscle weakness is a primary symptom of a variety of skeletal muscle diseases,
389:
The fundamental difference between the peripheral and central theories of muscle fatigue is that the peripheral model of muscle fatigue assumes failure at one or more sites in the chain that initiates muscle contraction. Peripheral regulation therefore depends on the localized metabolic chemical
316:
drive or nerve-based motor command to working muscles that results in a decline in the force output. It has been suggested that the reduced neural drive during exercise may be a protective mechanism to prevent organ failure if the work was continued at the same intensity. The exact mechanisms of
303:
Muscle fatigue can be central, neuromuscular, or peripheral muscular. Central muscle fatigue manifests as an overall sense of energy deprivation, and peripheral muscle weakness manifests as a local, muscle-specific inability to do work. Neuromuscular fatigue can be either central or peripheral.
351:. After an extended period of maximum contraction, the nerve's signal reduces in frequency and the force generated by the contraction diminishes. There is no sensation of pain or discomfort, the muscle appears to simply 'stop listening' and gradually cease to move, often 393:
Though not universally used, "metabolic fatigue" is a common alternative term for peripheral muscle weakness, because of the reduction in contractile force due to the direct or indirect effects of the reduction of substrates or accumulation of metabolites within the
250:
or perceived muscle weakness. For perceived muscle weakness, asthenia has been described as the feeling of weak or tired muscles in the absence of muscle weakness, that is the muscle can generate a normal amount of force but it is perceived as requiring more effort.
1248:
Newsholme, E. A., Acworth, I. N., & Blomstrand, E. 1987, 'Amino acids, brain neurotransmitters and a functional link between muscle and brain that is important in sustained exercise', in G Benzi (ed.), Advances in Myochemistry, Libbey Eurotext, London, pp.
165:
as a metabolic byproduct. Contrary to common belief, lactic acid accumulation doesn't actually cause the burning sensation felt when people exhaust their oxygen and oxidative metabolism, but in actuality, lactic acid in presence of oxygen recycles to produce
254:
General asthenia occurs in many chronic wasting diseases (such as tuberculosis and cancer), sleep disorders or chronic disorders of the heart, lungs or kidneys, and is probably most marked in diseases of the adrenal gland. Asthenia may be limited to certain
1392: 1377: 1362: 76:
of many different medical conditions. The causes are many and can be divided into conditions that have true or perceived muscle weakness. True muscle weakness is a primary symptom of a variety of skeletal muscle diseases, including
892:
Muscle tiredness: This is sometimes called asthenia. It is a sense of weariness or exhaustion that you feel when using the muscle. The muscle isn't genuinely weaker, it can still do its job but it takes you more effort to manage
278:
Differentiating psychogenic (perceived) asthenia and true asthenia from myasthenia is often difficult, and in time apparent psychogenic asthenia accompanying many chronic disorders is seen to progress into a primary weakness.
177:
Substrates produce metabolic fatigue by being depleted during exercise, resulting in a lack of intracellular energy sources to fuel contractions. In essence, the muscle stops contracting because it lacks the energy to do so.
385:
anaerobic metabolic by-products in the muscle, causing the stereotypical burning sensation of local muscle fatigue, though recent studies have indicated otherwise, actually finding that lactic acid is a source of energy.
373:
work force in 2002. This causes contractile dysfunction that manifests in the eventual reduction or lack of ability of a single muscle or local group of muscles to do work. The insufficiency of energy, i.e. sub-optimal
360:
level off once the nerve is generating maximum contractions and the muscle reaches its physiological limit. Past this point, training effects increase muscular strength through myofibrillar or sarcoplasmic
199:
Perceived weakness (or non-neuromuscular) describes a condition where a person feels more effort than normal is required to exert a given amount of force but actual muscle strength is normal, for example.
343:
For extremely powerful contractions that are close to the upper limit of a muscle's ability to generate force, neuromuscular fatigue can become a limiting factor in untrained individuals. In novice
246:) is a medical term referring to a condition in which the body lacks or has lost strength either as a whole or in any of its parts. It is a poorly defined condition that can include true or primary 2135: 1050:
Kay D, Marino FE, Cannon J, St Clair Gibson A, Lambert MI, Noakes TD (2001). "Evidence for neuromuscular fatigue during high-intensity cycling in warm, humid conditions".
212: 1852: 157:(ADP) and inorganic phosphate ions, allowing for sustained powerful contractions that last between 5–7 seconds. Glycogen is the intramuscular storage form of 336:
it becomes unable to stimulate the muscle that it innervates. Most movements require a force far below what a muscle could potentially generate, and barring
2120: 506: 215:, where objective post-exertion muscle weakness with delayed recovery time has been measured and is a feature of some of the published definitions. 534:
Paul L, Wood L, Behan WM, Maclaren WM (January 1999). "Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome".
1917: 1840: 1276: 948: 818: 720: 471: 1171:
Noakes TD (2000). "Physiological models to understand exercise fatigue and the adaptations that predict or enhance athletic performance".
192:
True weakness (or neuromuscular) describes a condition where the force exerted by the muscles is less than would be expected, for example
766:"Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise" 613: 1496: 518: 332:
control the contraction of muscles by determining the number, sequence, and force of muscular contraction. When a nerve experiences
268: 1093:
Vandewalle H, Maton B, Le Bozec S, Guerenbourg G (1991). "An electromyographic study of an all-out exercise on a cycle ergometer".
398:. This can occur through a simple lack of energy to fuel contraction, or through interference with the ability of Ca to stimulate 1128:
Bigland-Ritchie B, Woods JJ (1984). "Changes in muscle contractile properties and neural control during human muscular fatigue".
2125: 805:
Kauffman, Timothy L.; Kemmis, Karen (2014-01-01), Kauffman, Timothy L.; Scott, Ron; Barr, John O.; Moran, Michael L. (eds.),
1650:
Exaggerated cardiorespiratory response to exercise (tachycardia with tachypnea and/or hyperpnea (exercise hyperventilation))
1541: 972:
Kent-Braun JA (1999). "Central and peripheral contributions to muscle fatigue in humans during sustained maximal effort".
703:
Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; et al. (2003).
356: 705:
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols
2130: 1259:
Newsholme EA, Blomstrand E (1995). "Tryptophan, 5-Hydroxytryptamine and a Possible Explanation for Central Fatigue".
295:, such as myasthenia gravis. Perceived muscle weakness occurs in diseases such as sleep disorders, and depression. 263:, characterized by ready fatiguability. Asthenia is also a side effect of some medications and treatments, such as 150: 2083: 1910: 1871: 1705: 31: 1415: 130: 1805: 1214:
Davis JM (1995). "Carbohydrates, branched-chain amino acids, and endurance: the central fatigue hypothesis".
2040: 1634: 577:
McCully KK, Natelson BH (November 1999). "Impaired oxygen delivery to muscle in chronic fatigue syndrome".
1649: 1489: 641: 134: 124: 86: 806: 1859: 1536: 876: 292: 154: 82: 1903: 1847: 1629: 664:"A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome" 374: 1835: 1771: 1396: 1300:
R. Robergs; F. Ghiasvand; D. Parker (2004). "Biochemistry of exercise-induced metabolic acidosis".
931:
Gandevia SC, Enoka RM, McComas AJ, Stuart DG, Thomas CK (1995). "Neurobiology of Muscle Fatigue".
347:, the muscle's ability to generate force is most strongly limited by nerve's ability to sustain a 153:. Creatine phosphate stores energy so ATP can be rapidly regenerated within the muscle cells from 1995: 1879: 1810: 1761: 1685: 1665: 1325: 1196: 1153: 1075: 997: 738: 559: 488: 361: 352: 193: 133:
within the muscle generally serve to power muscular contractions. They include molecules such as
116: 102: 78: 1883: 1695: 1644: 1482: 1455: 1426: 1317: 1282: 1272: 1231: 1188: 1145: 1110: 1067: 1032: 989: 954: 944: 855: 814: 787: 726: 716: 685: 633: 594: 551: 514: 467: 344: 204: 161:, used to generate energy quickly once intramuscular creatine stores are exhausted, producing 90: 56: 1474: 2048: 2010: 1654: 1309: 1264: 1223: 1180: 1137: 1102: 1059: 1024: 981: 936: 843: 777: 708: 675: 625: 586: 543: 333: 211:
occurs after the muscle has been subjected to exercise. This is also true for some cases of
108: 1864: 1680: 1594: 750: 256: 247: 142: 1386: 1184: 317:
central fatigue are unknown, though there has been considerable interest in the role of
2099: 1794: 1756: 1675: 1624: 1604: 1599: 1577: 1409: 1401: 313: 283: 231: 1405: 905: 547: 418: 2114: 2053: 1783: 1700: 782: 765: 680: 663: 355:. As there is insufficient stress on the muscles and tendons, there will often be no 1200: 1157: 1079: 1001: 563: 2063: 1942: 1741: 1553: 1531: 1329: 1028: 395: 1420: 1268: 1263:. Advances in Experimental Medicine and Biology. Vol. 384. pp. 315–20. 940: 935:. Advances in Experimental Medicine and Biology. Vol. 384. pp. 515–25. 864:
Asthenia is a sense of weariness or exhaustion in the absence of muscle weakness.
629: 2068: 2025: 1952: 1947: 1926: 1875: 1690: 1659: 1566: 1450: 612:
De Becker P, Roeykens J, Reynders M, McGregor N, De Meirleir K (November 2000).
378: 348: 162: 1431: 1313: 149:
head and causes the 'ratchetting' that results in contraction according to the
2015: 1957: 1819: 1800: 1724: 1719: 1608: 1106: 1015:
Gandevia SC (2001). "Spinal and supraspinal factors in human muscle fatigue".
260: 171: 730: 2078: 2073: 1815: 1381: 1371: 1354: 337: 318: 264: 61: 1321: 1192: 1071: 1036: 993: 859: 791: 689: 637: 598: 555: 1286: 1235: 1227: 1149: 1141: 1114: 1063: 985: 958: 712: 312:
The central fatigue is generally described in terms of a reduction in the
1990: 1790: 1778: 1766: 1746: 1670: 1639: 1561: 1506: 167: 138: 764:
Jammes Y, Steinberg JG, Mambrini O, Brégeon F, Delliaux S (March 2005).
2005: 2000: 1980: 1967: 1715: 1526: 1095:
Archives Internationales de Physiologie, de Biochimie et de Biophysique
590: 158: 120: 73: 17: 466:(7th ed.). Philadelphia, PA: Mosby/Elsevier. p. Chapter 11. 2020: 1710: 1510: 1366: 403: 364:
and metabolic fatigue becomes the factor limiting contractile force.
291:
including muscular dystrophy and inflammatory myopathy. It occurs in
146: 2058: 1985: 1975: 1934: 1751: 1573: 974:
European Journal of Applied Physiology and Occupational Physiology
399: 329: 112: 1645:
Inappropriate rapid heart rate response to exercise (tachycardia)
1469: 811:
A Comprehensive Guide to Geriatric Rehabilitation (Third Edition)
30:
This article is about the medical condition. For other uses, see
1518: 382: 1899: 1478: 1895: 413: 272: 464:
Rosen's Emergency Medicine: Concepts and Clinical Practice
662:
De Becker P, McGregor N, De Meirleir K (September 2001).
511:
Adams and Victor's Principles of Neurology, Ninth Edition
1173:
Scandinavian Journal of Medicine & Science in Sports
807:"Chapter 16 - Muscle weakness and therapeutic exercise" 429: 1344: 906:"PubChem Compound Summary for CID 392622, Ritonavir" 877:"Muscle Weakness and Fatigue | Causes and Treatment" 2092: 2039: 1966: 1933: 1828: 1734: 1617: 1587: 1552: 1517: 1441: 1348: 813:, Oxford: Churchill Livingstone, pp. 112–119, 55: 47: 42: 213:Myalgic encephalomyelitis/chronic fatigue syndrome 844:"Evaluation of the Patient with Muscle Weakness" 489:"Finding May Solve Riddle of Fatigue in Muscles" 614:"Exercise capacity in chronic fatigue syndrome" 207:, muscle strength is normal when resting, but 1911: 1490: 8: 340:, neuromuscular fatigue is seldom an issue. 377:, generally results in the accumulation of 2136:Symptoms and signs: musculoskeletal system 1918: 1904: 1896: 1497: 1483: 1475: 1345: 39: 781: 679: 1216:International Journal of Sport Nutrition 454: 1302:Am J Physiol Regul Integr Comp Physiol 746: 736: 1841:Fibrodysplasia ossificans progressiva 837: 835: 7: 1185:10.1034/j.1600-0838.2000.010003123.x 282:Myasthenia or myasthaenia (my- from 170:in the liver, which is known as the 1640:Dynamic symptoms (exercise-induced) 2121:Symptoms and signs: Nervous system 487:Kolata, Gina (February 12, 2008). 25: 1408:before 10/01/03); alternatively, 548:10.1046/j.1468-1331.1999.610063.x 107:Muscle cells work by detecting a 783:10.1111/j.1365-2796.2005.01452.x 707:. Vol. 11. pp. 7–115. 681:10.1046/j.1365-2796.2001.00890.x 417: 111:of electrical impulses from the 1029:10.1152/physrev.2001.81.4.1725 585:(5): 603–8, discussion 611–3. 1: 509:; Samuels, Martin A. (2009). 357:delayed onset muscle soreness 1269:10.1007/978-1-4899-1016-5_25 941:10.1007/978-1-4899-1016-5_39 842:Saguil, Aaron (2005-04-01). 630:10.1001/archinte.160.21.3270 259:or systems of organs, as in 203:In some conditions, such as 187:True vs. perceived weakness 2152: 1314:10.1152/ajpregu.00114.2004 100: 29: 1872:Pseudoathletic appearance 1706:Intermittent claudication 1107:10.3109/13813459109145909 848:American Family Physician 368:Peripheral muscle fatigue 287: 235: 32:Weakness (disambiguation) 115:, which signals them to 1806:Rippling muscle disease 219:Asthenia vs. myasthenia 119:through the release of 2126:Neurological disorders 1784:Muscle channelopathies 1635:Myogenic hyperuricemia 426:This section is empty. 293:neuromuscular diseases 182:Differential diagnosis 151:sliding filament model 135:adenosine triphosphate 125:sarcoplasmic reticulum 87:neuromuscular junction 1681:Hyperthyroid myopathy 1228:10.1123/ijsn.5.s1.s29 1142:10.1002/mus.880070902 1064:10.1007/s004210000340 1052:Eur. J. Appl. Physiol 986:10.1007/s004210050558 713:10.1300/J092v11n01_02 349:high-frequency signal 325:Neuromuscular fatigue 155:adenosine diphosphate 83:inflammatory myopathy 1848:Compartment syndrome 1676:Hypothyroid myopathy 1666:Metabolic myopathies 1630:Exercise intolerance 1578:Hypothyroid myopathy 1860:Diastasis of muscle 1836:Myositis ossificans 462:Marx, John (2010). 145:. ATP binds to the 89:disorders, such as 2131:Muscular disorders 1880:Muscle hypertrophy 1876:Muscle hyperplasia 1811:Periodic paralysis 1762:Muscle contracture 1686:Hypoparathyroidism 1442:External resources 912:. 28 November 2022 591:10.1042/CS19980372 493:The New York Times 375:aerobic metabolism 269:protease inhibitor 194:muscular dystrophy 143:creatine phosphate 103:Muscle contraction 79:muscular dystrophy 2108: 2107: 1893: 1892: 1884:Pseudohypertrophy 1735:Abnormal movement 1618:Low ATP reservoir 1470:McArdle's disease 1465: 1464: 1278:978-1-4899-1018-9 1222:(Suppl): S29–38. 950:978-1-4899-1018-9 820:978-0-7020-4588-2 722:978-0-7890-2207-3 618:Arch. Intern. Med 473:978-0-323-05472-0 446: 445: 345:strength trainers 205:myasthenia gravis 91:myasthenia gravis 67: 66: 37:Medical condition 16:(Redirected from 2143: 2049:Acute bronchitis 2011:Nasal congestion 1996:Loss of appetite 1920: 1913: 1906: 1897: 1655:Hitting the wall 1499: 1492: 1485: 1476: 1346: 1334: 1333: 1297: 1291: 1290: 1256: 1250: 1246: 1240: 1239: 1211: 1205: 1204: 1168: 1162: 1161: 1125: 1119: 1118: 1090: 1084: 1083: 1047: 1041: 1040: 1012: 1006: 1005: 969: 963: 962: 928: 922: 921: 919: 917: 902: 896: 895: 889: 888: 873: 867: 866: 854:(7): 1327–1336. 839: 830: 829: 828: 827: 802: 796: 795: 785: 761: 755: 754: 748: 744: 742: 734: 700: 694: 693: 683: 659: 653: 652: 650: 649: 640:. Archived from 609: 603: 602: 574: 568: 567: 531: 525: 524: 507:Ropper, Allan H. 503: 497: 496: 484: 478: 477: 459: 441: 438: 428:You can help by 421: 414: 334:synaptic fatigue 289: 240:lack of strength 237: 40: 27:Physical symptom 21: 2151: 2150: 2146: 2145: 2144: 2142: 2141: 2140: 2111: 2110: 2109: 2104: 2100:Antiviral drugs 2088: 2035: 1962: 1929: 1924: 1894: 1889: 1865:Diastasis recti 1824: 1791:Pseudo-myotonia 1730: 1613: 1595:Muscle weakness 1583: 1548: 1513: 1503: 1466: 1461: 1460: 1437: 1436: 1357: 1343: 1338: 1337: 1299: 1298: 1294: 1279: 1258: 1257: 1253: 1247: 1243: 1213: 1212: 1208: 1170: 1169: 1165: 1127: 1126: 1122: 1092: 1091: 1087: 1058:(1–2): 115–21. 1049: 1048: 1044: 1014: 1013: 1009: 971: 970: 966: 951: 930: 929: 925: 915: 913: 904: 903: 899: 886: 884: 875: 874: 870: 841: 840: 833: 825: 823: 821: 804: 803: 799: 763: 762: 758: 745: 735: 723: 702: 701: 697: 661: 660: 656: 647: 645: 611: 610: 606: 576: 575: 571: 533: 532: 528: 521: 513:. McGraw-Hill. 505: 504: 500: 486: 485: 481: 474: 461: 460: 456: 451: 442: 436: 433: 412: 370: 327: 310: 308:Central fatigue 301: 248:muscle weakness 221: 189: 184: 105: 99: 97:Pathophysiology 85:. It occurs in 38: 35: 28: 23: 22: 15: 12: 11: 5: 2149: 2147: 2139: 2138: 2133: 2128: 2123: 2113: 2112: 2106: 2105: 2103: 2102: 2096: 2094: 2090: 2089: 2087: 2086: 2081: 2076: 2071: 2066: 2061: 2056: 2051: 2045: 2043: 2037: 2036: 2034: 2033: 2028: 2023: 2018: 2013: 2008: 2003: 1998: 1993: 1988: 1983: 1978: 1972: 1970: 1964: 1963: 1961: 1960: 1955: 1950: 1945: 1939: 1937: 1931: 1930: 1925: 1923: 1922: 1915: 1908: 1900: 1891: 1890: 1888: 1887: 1869: 1868: 1867: 1857: 1856: 1855: 1845: 1844: 1843: 1832: 1830: 1826: 1825: 1823: 1822: 1813: 1808: 1803: 1798: 1795:Brody myopathy 1788: 1787: 1786: 1776: 1775: 1774: 1769: 1759: 1757:Fasciculations 1754: 1749: 1744: 1738: 1736: 1732: 1731: 1729: 1728: 1722: 1713: 1708: 1703: 1698: 1696:Hypoxic muscle 1693: 1688: 1683: 1678: 1673: 1668: 1662: 1657: 1652: 1647: 1642: 1637: 1632: 1627: 1625:Muscle fatigue 1621: 1619: 1615: 1614: 1612: 1611: 1605:Muscle atrophy 1602: 1600:Rhabdomyolysis 1597: 1591: 1589: 1585: 1584: 1582: 1581: 1571: 1570: 1569: 1558: 1556: 1550: 1549: 1547: 1546: 1545: 1544: 1539: 1534: 1523: 1521: 1515: 1514: 1504: 1502: 1501: 1494: 1487: 1479: 1473: 1472: 1463: 1462: 1459: 1458: 1446: 1445: 1443: 1439: 1438: 1435: 1434: 1423: 1412: 1389: 1374: 1358: 1353: 1352: 1350: 1349:Classification 1342: 1341:External links 1339: 1336: 1335: 1308:(3): R502–16. 1292: 1277: 1251: 1241: 1206: 1163: 1120: 1085: 1042: 1023:(4): 1725–89. 1007: 964: 949: 923: 897: 868: 831: 819: 797: 776:(3): 299–310. 770:J. Intern. Med 756: 747:|journal= 721: 695: 668:J. Intern. Med 654: 624:(21): 3270–7. 604: 569: 536:Eur. J. Neurol 526: 520:978-0071499927 519: 498: 479: 472: 453: 452: 450: 447: 444: 443: 424: 422: 411: 408: 369: 366: 326: 323: 309: 306: 300: 297: 220: 217: 201: 200: 197: 188: 185: 183: 180: 98: 95: 65: 64: 59: 53: 52: 49: 45: 44: 36: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 2148: 2137: 2134: 2132: 2129: 2127: 2124: 2122: 2119: 2118: 2116: 2101: 2098: 2097: 2095: 2091: 2085: 2082: 2080: 2077: 2075: 2072: 2070: 2067: 2065: 2062: 2060: 2057: 2055: 2054:Bronchiolitis 2052: 2050: 2047: 2046: 2044: 2042: 2041:Complications 2038: 2032: 2029: 2027: 2024: 2022: 2019: 2017: 2014: 2012: 2009: 2007: 2004: 2002: 1999: 1997: 1994: 1992: 1989: 1987: 1984: 1982: 1979: 1977: 1974: 1973: 1971: 1969: 1965: 1959: 1956: 1954: 1951: 1949: 1946: 1944: 1941: 1940: 1938: 1936: 1932: 1928: 1921: 1916: 1914: 1909: 1907: 1902: 1901: 1898: 1885: 1881: 1877: 1873: 1870: 1866: 1863: 1862: 1861: 1858: 1854: 1851: 1850: 1849: 1846: 1842: 1839: 1838: 1837: 1834: 1833: 1831: 1827: 1821: 1817: 1814: 1812: 1809: 1807: 1804: 1802: 1799: 1796: 1792: 1789: 1785: 1782: 1781: 1780: 1777: 1773: 1770: 1768: 1765: 1764: 1763: 1760: 1758: 1755: 1753: 1750: 1748: 1745: 1743: 1740: 1739: 1737: 1733: 1726: 1723: 1721: 1717: 1714: 1712: 1709: 1707: 1704: 1702: 1701:Pseudohypoxia 1699: 1697: 1694: 1692: 1689: 1687: 1684: 1682: 1679: 1677: 1674: 1672: 1669: 1667: 1663: 1661: 1658: 1656: 1653: 1651: 1648: 1646: 1643: 1641: 1638: 1636: 1633: 1631: 1628: 1626: 1623: 1622: 1620: 1616: 1610: 1606: 1603: 1601: 1598: 1596: 1593: 1592: 1590: 1586: 1579: 1575: 1572: 1568: 1565: 1564: 1563: 1560: 1559: 1557: 1555: 1551: 1543: 1542:Delayed onset 1540: 1538: 1535: 1533: 1530: 1529: 1528: 1525: 1524: 1522: 1520: 1516: 1512: 1508: 1505:Symptoms and 1500: 1495: 1493: 1488: 1486: 1481: 1480: 1477: 1471: 1468: 1467: 1457: 1453: 1452: 1448: 1447: 1444: 1440: 1433: 1429: 1428: 1424: 1422: 1418: 1417: 1413: 1411: 1407: 1403: 1399: 1398: 1394: 1390: 1388: 1384: 1383: 1379: 1375: 1373: 1369: 1368: 1364: 1360: 1359: 1356: 1351: 1347: 1340: 1331: 1327: 1323: 1319: 1315: 1311: 1307: 1303: 1296: 1293: 1288: 1284: 1280: 1274: 1270: 1266: 1262: 1255: 1252: 1245: 1242: 1237: 1233: 1229: 1225: 1221: 1217: 1210: 1207: 1202: 1198: 1194: 1190: 1186: 1182: 1179:(3): 123–45. 1178: 1174: 1167: 1164: 1159: 1155: 1151: 1147: 1143: 1139: 1135: 1131: 1124: 1121: 1116: 1112: 1108: 1104: 1100: 1096: 1089: 1086: 1081: 1077: 1073: 1069: 1065: 1061: 1057: 1053: 1046: 1043: 1038: 1034: 1030: 1026: 1022: 1018: 1011: 1008: 1003: 999: 995: 991: 987: 983: 979: 975: 968: 965: 960: 956: 952: 946: 942: 938: 934: 927: 924: 911: 907: 901: 898: 894: 882: 878: 872: 869: 865: 861: 857: 853: 849: 845: 838: 836: 832: 822: 816: 812: 808: 801: 798: 793: 789: 784: 779: 775: 771: 767: 760: 757: 752: 740: 732: 728: 724: 718: 714: 710: 706: 699: 696: 691: 687: 682: 677: 674:(3): 234–40. 673: 669: 665: 658: 655: 644:on 2011-08-12 643: 639: 635: 631: 627: 623: 619: 615: 608: 605: 600: 596: 592: 588: 584: 580: 573: 570: 565: 561: 557: 553: 549: 545: 541: 537: 530: 527: 522: 516: 512: 508: 502: 499: 494: 490: 483: 480: 475: 469: 465: 458: 455: 448: 440: 431: 427: 423: 420: 416: 415: 409: 407: 406:to contract. 405: 401: 397: 391: 387: 384: 380: 376: 367: 365: 363: 358: 354: 350: 346: 341: 339: 335: 331: 324: 322: 320: 315: 307: 305: 298: 296: 294: 285: 280: 276: 275:treatment). 274: 270: 266: 262: 258: 252: 249: 245: 241: 233: 229: 225: 218: 216: 214: 210: 209:true weakness 206: 198: 195: 191: 190: 186: 181: 179: 175: 173: 169: 164: 160: 156: 152: 148: 144: 140: 136: 132: 128: 126: 122: 118: 114: 110: 104: 96: 94: 92: 88: 84: 80: 75: 71: 63: 60: 58: 54: 50: 46: 41: 33: 19: 2084:Strep throat 2064:Otitis media 2030: 2006:Muscle aches 1752:Muscle spasm 1742:Muscle cramp 1554:Inflammation 1532:Fibromyalgia 1509:relating to 1449: 1425: 1414: 1391: 1376: 1361: 1305: 1301: 1295: 1260: 1254: 1244: 1219: 1215: 1209: 1176: 1172: 1166: 1136:(9): 691–9. 1133: 1130:Muscle Nerve 1129: 1123: 1101:(1): 89–93. 1098: 1094: 1088: 1055: 1051: 1045: 1020: 1017:Physiol. Rev 1016: 1010: 980:(1): 57–63. 977: 973: 967: 932: 926: 914:. Retrieved 909: 900: 891: 885:. Retrieved 883:. 2021-06-28 881:patient.info 880: 871: 863: 851: 847: 824:, retrieved 810: 800: 773: 769: 759: 704: 698: 671: 667: 657: 646:. Retrieved 642:the original 621: 617: 607: 582: 578: 572: 539: 535: 529: 510: 501: 492: 482: 463: 457: 437:October 2017 434: 430:adding to it 425: 392: 388: 371: 342: 328: 319:serotonergic 311: 302: 281: 277: 253: 243: 239: 238:, literally 227: 223: 222: 208: 202: 176: 129: 106: 69: 68: 2069:Pharyngitis 2026:Sore throat 1953:Enterovirus 1948:Coronavirus 1927:Common cold 1691:Hypokalemia 1660:Second wind 1588:Destruction 1567:Pyomyositis 1451:MedlinePlus 916:28 November 542:(1): 63–9. 379:lactic acid 362:hypertrophy 353:lengthening 163:lactic acid 48:Other names 2115:Categories 2016:Rhinorrhea 1958:Rhinovirus 1943:Adenovirus 1820:Hypertonia 1801:Spasticity 1725:Alcoholism 1720:Starvation 1609:Amyotrophy 1507:conditions 1427:DiseasesDB 887:2023-11-19 826:2023-11-19 648:2011-03-12 449:References 410:Management 381:and other 321:pathways. 261:asthenopia 172:Cori cycle 131:Substrates 101:See also: 2079:Sinusitis 2074:Pneumonia 1816:Hypotonia 749:ignored ( 739:cite book 731:1057-3321 579:Clin. Sci 338:pathology 265:Ritonavir 242:but also 228:asthaenia 62:Neurology 57:Specialty 2031:Weakness 2021:Sneezing 1991:Headache 1968:Symptoms 1853:Anterior 1779:Myotonia 1772:Adhesion 1767:Fibrosis 1747:Myokymia 1671:Diabetes 1574:Myoedema 1562:Myositis 1322:15308499 1249:127-133. 1201:23103331 1193:10843507 1158:13606531 1080:25906759 1072:11394239 1037:11581501 1002:22515865 994:10367724 860:15832536 792:15715687 690:11555128 638:11088089 599:10545311 564:33480143 556:10209352 396:myocytes 271:used in 236:ἀσθένεια 224:Asthenia 168:pyruvate 139:glycogen 117:contract 70:Weakness 51:Asthenia 43:Weakness 2001:Malaise 1981:Fatigue 1935:Viruses 1716:Fasting 1527:Myalgia 1421:D018908 1330:2745168 1287:8585461 1261:Fatigue 1236:7550256 1150:6100456 1115:1713492 959:8585476 933:Fatigue 244:disease 159:glucose 137:(ATP), 123:by the 121:calcium 74:symptom 18:Weakest 1711:Scurvy 1511:muscle 1456:003174 1410:780.79 1402:728.87 1328:  1320:  1285:  1275:  1234:  1199:  1191:  1156:  1148:  1113:  1078:  1070:  1035:  1000:  992:  957:  947:  858:  817:  790:  729:  719:  688:  636:  597:  562:  554:  517:  470:  404:myosin 383:acidic 330:Nerves 314:neural 257:organs 147:myosin 2093:Drugs 2059:Croup 1986:Fever 1976:Cough 1829:Other 1537:Acute 1432:22832 1406:728.9 1387:R53.1 1382:10-CM 1326:S2CID 1197:S2CID 1154:S2CID 1076:S2CID 998:S2CID 560:S2CID 400:actin 299:Types 284:Greek 232:Greek 113:brain 72:is a 1519:Pain 1416:MeSH 1397:9-CM 1318:PMID 1283:PMID 1273:ISBN 1232:PMID 1189:PMID 1146:PMID 1111:PMID 1068:PMID 1033:PMID 990:PMID 955:PMID 945:ISBN 918:2022 910:NCBI 856:PMID 815:ISBN 788:PMID 751:help 727:ISSN 717:ISBN 686:PMID 634:PMID 595:PMID 552:PMID 515:ISBN 468:ISBN 402:and 141:and 109:flow 81:and 1393:ICD 1378:ICD 1372:R53 1363:ICD 1310:doi 1306:287 1265:doi 1224:doi 1181:doi 1138:doi 1103:doi 1060:doi 1025:doi 982:doi 937:doi 893:it. 778:doi 774:257 709:doi 676:doi 672:250 626:doi 622:160 587:doi 544:doi 432:. 288:μυο 273:HIV 267:(a 226:or 2117:: 1882:/ 1878:/ 1818:/ 1718:/ 1454:: 1430:: 1419:: 1400:: 1385:: 1370:: 1367:10 1324:. 1316:. 1304:. 1281:. 1271:. 1230:. 1218:. 1195:. 1187:. 1177:10 1175:. 1152:. 1144:. 1132:. 1109:. 1099:99 1097:. 1074:. 1066:. 1056:84 1054:. 1031:. 1021:81 1019:. 996:. 988:. 978:80 976:. 953:. 943:. 908:. 890:. 879:. 862:. 852:71 850:. 846:. 834:^ 809:, 786:. 772:. 768:. 743:: 741:}} 737:{{ 725:. 715:. 684:. 670:. 666:. 632:. 620:. 616:. 593:. 583:97 581:. 558:. 550:. 538:. 491:. 286:: 234:: 174:. 93:. 1919:e 1912:t 1905:v 1886:) 1874:( 1797:) 1793:( 1727:) 1664:( 1607:/ 1580:) 1576:( 1498:e 1491:t 1484:v 1404:( 1395:- 1380:- 1365:- 1355:D 1332:. 1312:: 1289:. 1267:: 1238:. 1226:: 1220:5 1203:. 1183:: 1160:. 1140:: 1134:7 1117:. 1105:: 1082:. 1062:: 1039:. 1027:: 1004:. 984:: 961:. 939:: 920:. 794:. 780:: 753:) 733:. 711:: 692:. 678:: 651:. 628:: 601:. 589:: 566:. 546:: 540:6 523:. 495:. 476:. 439:) 435:( 230:( 196:. 34:. 20:)

Index

Weakest
Weakness (disambiguation)
Specialty
Neurology
symptom
muscular dystrophy
inflammatory myopathy
neuromuscular junction
myasthenia gravis
Muscle contraction
flow
brain
contract
calcium
sarcoplasmic reticulum
Substrates
adenosine triphosphate
glycogen
creatine phosphate
myosin
sliding filament model
adenosine diphosphate
glucose
lactic acid
pyruvate
Cori cycle
muscular dystrophy
myasthenia gravis
Myalgic encephalomyelitis/chronic fatigue syndrome
Greek

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.